14 results
10-K
2023 FY
NAMS
NewAmsterdam Pharma Company N.V.
28 Feb 24
Annual report
8:00am
is implemented by various regulations and rules. The primary drug authority that regulates the life cycle of drugs is the NMPA. The NMPA has its own set … company is responsible for the life cycle of the product, including development, production and distribution, post-market trials, routine annual
424B3
NAMS
NewAmsterdam Pharma Company N.V.
15 Aug 23
Prospectus supplement
4:52pm
that regulates the life cycle of drugs is the NMPA. The NMPA has its own set of regulations, rules and guidelines further implementing the DAL. The rule … is responsible for the life cycle of the product, including development, production and distribution, post-market studies, routine annual reporting, and safety
POS AM
NAMS
NewAmsterdam Pharma Company N.V.
7 Aug 23
Prospectus update (post-effective amendment)
7:56am
by various regulations and rules. The primary drug authority that regulates the life cycle of drugs is the NMPA. The NMPA has its own set of regulations … .
As the marketing authorization holder (“MAH”), a drug company is responsible for the life cycle of the product, including development, production
424B3
NAMS
NewAmsterdam Pharma Company N.V.
8 Jun 23
Prospectus supplement
5:01pm
and rules. The primary drug authority that regulates the life cycle of drugs is the NMPA. The NMPA has its own set of regulations further implementing … , regulations, rules, and guidelines governing almost all of the key stages of the life-cycle of pharmaceutical products, including nonclinical studies
424B3
NAMS
NewAmsterdam Pharma Company N.V.
6 Jun 23
Prospectus supplement
4:20pm
authority that regulates the life cycle of drugs is the NMPA. The NMPA has its own set of regulations further implementing the DAL. The regulation … , and guidelines governing almost all of the key stages of the life-cycle of pharmaceutical products, including nonclinical studies, clinical trials, marketing
424B3
6xzc8n63mckjin43 zf
25 Apr 23
Prospectus supplement
8:14am
POS AM
7bxhu7wdv
17 Apr 23
Prospectus update (post-effective amendment)
9:09am
F-1
et5lg1hzw vbhhrjmpos
19 Dec 22
Registration statement (foreign)
6:22pm
424B3
ysh25y
18 Oct 22
Prospectus supplement
4:41pm
F-4/A
i06x3r9e
13 Oct 22
Registration of securities (foreign) (amended)
5:18pm
F-4/A
8d4sxkq2
3 Oct 22
Registration of securities (foreign) (amended)
5:12pm
F-4/A
qk8 s346jg1vsmairxl
13 Sep 22
Registration of securities (foreign) (amended)
5:03pm
F-4
i3vci3r
4 Aug 22
Registration of securities (foreign)
8:02am
- Prev
- 1
- Next